BIOLASE, INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Biolase, Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • Biolase, Inc Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 33.4M shares, a 3178% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 33.4M +32.4M +3178% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 33.3M +6.93M +26.3% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 3.42M +3.34M +4336% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 2.27M -4.88M -68.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.02M -5.84M -85.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 26.3M +20.2M +326% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 77K -6.07M -98.7% Dec 31, 2022 10-K 2024-03-21
Q3 2022 7.14M -146M -95.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 6.86M -144M -95.5% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 6.18M -143M -95.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 6.15M -91.6M -93.7% Dec 31, 2021 10-K 2023-03-28
Q3 2021 153M +60.3M +64.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 151M +101M +200% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 149M +118M +373% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 97.7M +66.3M +211% Dec 31, 2020 10-K 2022-03-17
Q3 2020 93M +93M Sep 30, 2020 10-Q 2020-11-13
Q2 2020 50.4M +50.4M Jun 30, 2020 10-Q 2020-08-14
Q1 2020 31.6M +31.6M Mar 31, 2020 10-Q 2020-05-08
Q4 2019 31.4M +9.47M +43.1% Dec 31, 2019 10-K 2021-03-31
Q3 2019 22K* -20.6M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 21.9K* -20.6M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 21.3K* -102M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 22M +1.5M +7.35% Dec 31, 2018 10-K 2020-03-30
Q3 2018 20.7M -55.4M -72.8% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 20.6M -55.4M -72.9% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 102M +34.7M +51.3% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 20.5M -47.1M -69.7% Dec 31, 2017 10-K 2019-03-08
Q3 2017 76M +8.45M +12.5% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 76M +17.7M +30.4% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 67.7M +9.4M +16.1% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 67.6M +9.34M +16% Dec 31, 2016 10-K 2018-03-14
Q3 2016 67.6M +9.34M +16% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 58.3M +69K +0.12% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 58.3M +104K +0.18% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 58.2M +113K +0.19% Dec 31, 2015 10-K 2017-03-10
Q3 2015 58.2M +14.3M +32.5% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 58.2M +18.6M +46.9% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 58.2M +18.6M +46.9% Mar 31, 2015 10-Q 2015-05-01
Q4 2014 58.1M +20.8M +55.7% Dec 31, 2014 10-K 2016-03-11
Q3 2014 44M +7.14M +19.4% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 39.6M +5.64M +16.6% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 39.6M +6.1M +18.2% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 37.3M +4.09M +12.3% Dec 31, 2013 10-K 2015-03-06
Q3 2013 36.8M +3.73M +11.3% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 34M +932K +2.82% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 33.5M +718K +2.19% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 33.2M +746K +2.3% Dec 31, 2012 10-K 2014-03-17
Q3 2012 33.1M +824K +2.55% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 33M +1.22M +3.83% Jun 30, 2012 10-Q/A 2012-09-06
Q1 2012 32.8M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 32.5M +5.94M +22.3% Dec 31, 2011 10-K 2013-03-15
Q3 2011 32.3M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 31.8M Jun 30, 2011 10-Q 2011-08-11
Q4 2010 26.6M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.